Origent can rapidly develop and deploy new predictive models for virtually any disease.  On a brand new disease, using your clinical dataset, we generally expect to deploy high-performance predictive models within the first 30 days, with continuous improvement thereafter.

Origent also maintains a portfolio of existing in-house models, which are ready-to-deploy immediately.  Our existing model portfolio is most extensive in Amyotrophic Lateral Sclerosis and Alzheimer’s disease, and we are actively expanding our model library to include other disease areas.

Select any of the disease areas below to learn more.